MORPHIC HOLDING INC (MORF) Stock Price, Quote, News and Overview
NASDAQ:MORF - Nasdaq - US61775R1059 - Common Stock - Currency: USD
MORF Quote, Performance and Key Statistics
MORPHIC HOLDING INC
NASDAQ:MORF (8/15/2024, 8:13:37 PM)
After market: 56.99 0 (0%)56.99
+0.02 (+0.04%)
The current stock price of MORF is 56.99 USD. In the past month the price increased by 1.19%. In the past year, price increased by 5.11%.
MORF Latest News, Press Releases and Analysis
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Morphic Holding, Inc. (NASDAQ: MORF). Morphic...
Eli Lilly Taps Blue-Chip Bond Market to Fund Morphic Acquisition
Eli Lilly & Co. is selling US investment-grade bonds on Monday to fund its $3.2 billion acquisition of gut-drug maker Morphic Holding Inc., after recession fears triggered a turbulent week.
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, DRQ, SSB, MORF on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMNF, MORF, BALY on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders
MORF Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.77 | 335.67B | ||
| AMGN | AMGEN INC | 14.58 | 155.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 945.65 | 124.20B | ||
| GILD | GILEAD SCIENCES INC | 22.12 | 122.12B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.27 | 76.60B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.08B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.76B | ||
| NTRA | NATERA INC | N/A | 23.00B | ||
| BIIB | BIOGEN INC | 8.73 | 20.76B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.78B |
Related stock screener links
About MORF
Company Profile
Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. The company is headquartered in Waltham, Massachusetts and currently employs 124 full-time employees. The company went IPO on 2019-06-27. The firm is engaged in discovering and developing a pipeline of potentially oral small molecule integrin therapeutics for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. The Company’s Morphic integrin technology platform (MInT Platform) helps to develop product candidates designed to achieve the potency, high selectivity and pharmaceutical properties required for oral administration. The firm is advancing its pipeline, including its lead product candidate, MORF-057, an orally administered a4b7-specific integrin inhibitor affecting inflammation, into clinical development for the treatment of inflammatory bowel disease (IBD). The company has also developed avb6-specific integrin inhibitors for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF) and additional indications.
Company Info
MORPHIC HOLDING INC
35 Gatehouse Drive A2
Waltham MASSACHUSETTS 02451 US
CEO: Praveen P. Tipirneni
Employees: 124
Company Website: https://morphictx.com/
Phone: 17819960955
MORF FAQ
What is the stock price of MORF?
The current stock price of MORF is 56.99 USD.
What is the symbol for MORPHIC HOLDING INC stock?
The exchange symbol of MORPHIC HOLDING INC is MORF and it is listed on the Nasdaq exchange.
On which exchange is MORF stock listed?
MORF stock is listed on the Nasdaq exchange.
Is MORF a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MORF, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MORF.
Does MORF stock pay dividends?
MORF does not pay a dividend.
When does MORF stock report earnings?
MORF will report earnings on 2024-11-01, before the market open.
What is the Price/Earnings (PE) ratio of MORF?
MORF does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.75).
MORF Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to MORF. When comparing the yearly performance of all stocks, MORF is one of the better performing stocks in the market, outperforming 94.75% of all stocks.
MORF Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MORF. While MORF has a great health rating, there are worries on its profitability.
MORF Financial Highlights
Over the last trailing twelve months MORF reported a non-GAAP Earnings per Share(EPS) of -3.75. The EPS increased by -15.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.83% | ||
| ROE | -29.08% | ||
| Debt/Equity | 0 |
MORF Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 73% to MORF. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of -16.05% and a revenue growth -50.42% for MORF